A triple combination of latanoprost, fractional CO 2 laser, and platelet‐rich plasma in localized vitiligo: A clinical and histopathologic study
Photodermatology, Photoimmunology & Photomedicine · 2024-01 · 40 (1)
DOI: 10.1111/phpp.12944 ↗At a glance
Randomisierte kontrollierte Studie in Photodermatology, Photoimmunology & Photomedicine, published online on 2024-01-10. Written by Salma Samir Omar and 4 co-authors. Institution: Department of Dermatology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Major MEDLINE topics: Lasers, Gas, Platelet-Rich Plasma, Vitiligo. Cited 10 times so far (Crossref); 32 references.
Abstract (original language)
Background
Several treatment modalities are available for the treatment of vitiligo due to the lack of a uniformly effective therapy. Topical latanoprost 0.005% is an effective topical treatment. Fractional CO 2 laser alone or combined with platelet‐rich plasma (PRP) has been proposed as effective adjunctive therapies.
Objectives
We aimed to compare the efficacy of topical latanoprost 0.005% (Ioprost®, Orchidia, Egypt) combined with either add‐on fractional CO 2 laser or fractional CO 2 ‐PRP versus topical latanoprost monotherapy in the treatment of localized stable vitiligo. Patients/Methods The study included 60 patients randomly assigned into three equal groups. Group A patients received topical latanoprost drops only. Group B patients received topical latanoprost drops and fractional CO 2 laser sessions at 2‐week interval for 3 months. Group C patients received topical latanoprost drops and fractional CO 2 laser sessions combined with PRP at a 2‐week interval for 3 months. The mean improvement score by the physician was calculated 4 months after the start of the study. Punch skin biopsies were obtained before treatment and 4 months from the beginning of the study and stained with H&E and HMB‐45 antibody for evaluation of pigmentation.
Results
Significant clinical improvement of vitiligo lesions with significant increase of re‐pigmentation were reported in the three treated groups. Latanoprost in combination with fractional CO 2 and PRP was associated with more significant therapeutic outcomes than either combined latanoprost and fractional CO 2 or latanoprost alone.
Conclusion
Fractional CO 2 laser‐PRP enhances the therapeutic efficacy of latanoprost 0.005% in the treatment of localized stable vitiligo.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Alexandria Police Hospital, Alexandria, Egypt.
ORCID profiles: Salma Samir Omar
Cite
APA
Omar, S. S., Elmulla, K. F., Aly, R. G., Elkaffas, A., & Ismail, A. (2024). A triple combination of latanoprost, fractional CO 2 laser, and platelet‐rich plasma in localized vitiligo: A clinical and histopathologic study. Photodermatology, Photoimmunology & Photomedicine, 40(1). https://doi.org/10.1111/phpp.12944
Vancouver
Omar SS, Elmulla KF, Aly RG, Elkaffas A, Ismail A. A triple combination of latanoprost, fractional CO 2 laser, and platelet‐rich plasma in localized vitiligo: A clinical and histopathologic study. Photodermatology, Photoimmunology & Photomedicine. 2024;40(1). doi:10.1111/phpp.12944
BibTeX
@article{Omar2024,
author = {Omar, Salma Samir and Elmulla, Khaled Fawzy and Aly, Rania Gaber and Elkaffas, Ahmed and Ismail, Aliaa},
title = {A triple combination of latanoprost, fractional CO 2 laser, and platelet‐rich plasma in localized vitiligo: A clinical and histopathologic study},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2024},
volume = {40},
number = {1},
doi = {10.1111/phpp.12944}
}
EUVIMED